Literature DB >> 33317028

Role of Natural Killer Cells in Uveal Melanoma.

Asad Javed1,2, Mohammed Milhem1,2.   

Abstract

Uveal melanoma has a high mortality rate following metastasis to the liver. Despite advances in systemic immune therapy, treatment of metastatic uveal melanoma (MUM) has failed to achieve long term durable responses. Barriers to success with immune therapy include the immune regulatory nature of uveal melanoma as well as the immune tolerant environment of the liver. To adequately harness the anti-tumor potential of the immune system, non-T cell-based approaches need to be explored. Natural Killer (NK) cells possess potent ability to target tumor cells via innate and adaptive responses. In this review, we discuss evidence that highlights the role of NK cell surveillance and targeting of uveal melanoma. We also discuss the repertoire of intra-hepatic NK cells. The human liver has a vast and diverse lymphoid population and NK cells comprise 50% of the hepatic lymphocytes. Hepatic NK cells share a common niche with uveal melanoma micro-metastasis within the liver sinusoids. It is, therefore, crucial to understand and investigate the role of intra-hepatic NK cells in the control or progression of MUM.

Entities:  

Keywords:  NK cells; liver-resident NK cells; uveal melanoma

Year:  2020        PMID: 33317028      PMCID: PMC7764114          DOI: 10.3390/cancers12123694

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  179 in total

1.  An activating immunoreceptor complex formed by NKG2D and DAP10.

Authors:  J Wu; Y Song; A B Bakker; S Bauer; T Spies; L L Lanier; J H Phillips
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

2.  Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye.

Authors:  R S Apte; J Y Niederkorn
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

3.  Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.

Authors:  Andrea G M Scholes; Bertil E Damato; Janice Nunn; Paul Hiscott; Ian Grierson; John K Field
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

4.  Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

Authors:  Willem Maat; Arno R van der Slik; Dirk H J Verhoeven; Behrooz Z Alizadeh; Long V Ly; Willem Verduijn; Gregorius P M Luyten; Arend Mulder; Thorbald van Hall; Frits Koning; Martine J Jager; Jeroen van Bergen
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

5.  Incidence of uveal melanoma in Europe.

Authors:  Gianni Virgili; Gemma Gatta; Laura Ciccolallo; Riccardo Capocaccia; Annibale Biggeri; Emanuele Crocetti; Jean-Michel Lutz; Eugenio Paci
Journal:  Ophthalmology       Date:  2007-05-11       Impact factor: 12.079

6.  Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.

Authors:  Hua Yang; Stefan Dithmar; Hans E Grossniklaus
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

7.  The Interferon-Gamma Paradox in Cancer.

Authors:  M Raza Zaidi
Journal:  J Interferon Cytokine Res       Date:  2018-11-09       Impact factor: 2.607

8.  Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma.

Authors:  V A White; J D Chambers; P D Courtright; W Y Chang; D E Horsman
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

9.  Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation.

Authors:  Antonia O Cuff; Francis P Robertson; Kerstin A Stegmann; Laura J Pallett; Mala K Maini; Brian R Davidson; Victoria Male
Journal:  J Immunol       Date:  2016-10-21       Impact factor: 5.422

10.  Expression of immune checkpoint receptors Indoleamine 2,3-dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma.

Authors:  Gustav Stålhammar; Stefan Seregard; Hans E Grossniklaus
Journal:  Cancer Med       Date:  2019-04-16       Impact factor: 4.452

View more
  4 in total

Review 1.  The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.

Authors:  Anna Hagström; Ruba Kal Omar; Pete A Williams; Gustav Stålhammar
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

2.  A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy.

Authors:  Celine A Fadel; Swathi Kanakamedala; Shivang U Danak; Andrew T Johnson
Journal:  Cureus       Date:  2022-06-21

3.  CD8 Positive T Lymphocyte Infiltration of Liver Metastases of Uveal Melanoma: A Case Report.

Authors:  Naoki Takahashi; Kazuto Tajiri; Ko Kagoyana; Shinichi Tanaka; Ichiro Yasuda
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

4.  Immunological significance of survival-related alternative splicing in uveal melanoma.

Authors:  Deqian Kong; Li Li; Huajun Wang; Ke Li; Guangying Zheng
Journal:  Aging (Albany NY)       Date:  2022-01-19       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.